Lab21 strengthens fungal infection testing presence with Myconostica buy
This article was originally published in Clinica
Executive Summary
UK personalised medicine firm Lab21 has boosted its diagnostic portfolio by acquiring fungal infection testing specialist Myconostica for an undisclosed fee.